Acute Coronary Syndrome News and Research

RSS

SENIOR trial: Shorter DAPT combined with Synergy stent superior to BMS in elderly patients

Elderly patients undergoing PCI often receive bare-metal stents (BMS) instead of drug-eluting stents (DES) to shorten the duration of dual antiplatelet therapy (DAPT) and reduce bleeding risk. However, results from the SENIOR trial found that compared with BMS, shorter DAPT combined with the Synergy bioabsorbable polymer DES leads to less adverse events without increasing bleeding risk.

2 Nov 2017

Two protocols help assess patients with chest pain quickly and safely in emergency departments

Two protocols for quickly and safely evaluating patients presenting to emergency departments with chest pain are being adopted by Australian hospitals.

11 Sep 2017

New ESC Focused Update provides recommendations on DAPT in patients with coronary artery disease

The first ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease is published online today in European Heart Journal, and on the ESC website.

26 Aug 2017

University of Birmingham joins €19 million project to develop better treatments for heart disease

The University of Birmingham is part of a major new €19 million project aimed at breaking new ground for the development of treatments for millions of patients with heart disease in Europe.

19 Jul 2017

Study looks at role of race, gender in predicting heart attack symptoms in emergency department

Researchers at the George Washington University found that certain symptoms are more and less predictive of patients' risk for acute coronary syndrome, which includes heart attack, in patients of different gender and race.

23 Jun 2017

Intensive blood pressure lowering reduces CKD patients' risks of heart disease and death

Results from a recent clinical trial indicate that intensive blood pressure lowering reduces chronic kidney disease patients' risks of dying prematurely or developing cardiovascular disease. The findings appear in an upcoming issue of the Journal of the American Society of Nephrology.

23 Jun 2017

Philips showcase image guided therapy solutions at EuroPCR 2017

Royal Philips will showcase its market-leading image guided therapy solutions at EuroPCR 2017 (Paris, May 16 – 19, 2017) to advance interventional cardiology and make care more personalized, while optimizing patient care and hospital budgets. This year, the healthcare industry is celebrating the 40th anniversary of angioplasty, the minimally invasive treatment of obstructed blood vessels, and as a leader in interventional cardiology, Philips is reinforcing its longstanding commitment to transforming cardiac care with meaningful innovations.

17 May 2017

New stenting tool found to be less painful and cheaper than current methods

A new tool for assessing the narrowing of the heart's arteries was found to be as effective as current methods and less painful for patients.

21 Mar 2017

New iFR technique for assessing clogged arteries reduces discomfort and adverse events

For patients experiencing angina (chest pain) or a heart attack, a new tool called instantaneous wave-free ratio (iFR) was equivalent to the currently-preferred tool, fractional flow reserve (FFR), in terms of incidence of major adverse events according to two studies presented at the American College of Cardiology's 66th Annual Scientific Session. The studies also showed iFR resulted in markedly less patient discomfort and reduced procedure-related adverse events compared to FFR.

20 Mar 2017

Novel synthetic HDL-C injection shows no benefit on arterial plaques

Injection of a novel form of synthetic high-density lipoprotein cholesterol (HDL-C), or good cholesterol, into the arteries of patients who had recently had a heart attack did not reduce the volume of fatty deposits, or plaque, in the arteries, compared with placebo injections, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.

20 Mar 2017

High levels of two biomarkers can predict risk for adverse cardiac events, research suggests

New research suggests that GlycA, a newly identified blood marker, and C-reactive protein both independently predict major adverse cardiac events, including heart failure and death. Patients who have high levels of both biomarkers are at especially high risk.

17 Mar 2017

Study finds only 16% of heart attack survivors get recommended amount of physical activity

Only 16 percent of heart attack survivors get the recommended amount of physical activity in the weeks after hospitalization, according to a study by researchers at Columbia University Medical Center and NewYork-Presbyterian.

1 Mar 2017

European hospital introduces Philips Minicare cTnI point-of-care blood test for rapid diagnosis of heart attack

Elkerliek Hospital (Helmond, the Netherlands) and Royal Philips, a leader in HealthTech, today announced their collaboration to pioneer the use of point-of-care testing in the hospital’s dedicated cardiac emergency department.

From Philips Healthcare 1 Mar 2017

OU study identifies numeracy as decision delay risk factor for individuals experiencing ACS

In a recent study to determine why some individuals who experience symptoms for acute coronary syndrome decide to seek medical attention more quickly than others, a University of Oklahoma researcher has identified numeracy -- the ability to understand and apply numerical concepts as the primary decision delay risk factor for individuals experiencing the medical condition.

28 Feb 2017

Thought leaders at U-CARS meeting to explore issues related to heart recovery and regeneration

For many years, the answer to that question was unequivocally "No." But as the University of Utah School of Medicine's annual Utah Cardiac Recovery Symposium will explore on Jan. 12-13, advances in treating heart failure are giving physicians, surgeons and researchers reason to hope the deadly disease might one day be defeated.

6 Jan 2017

Study evaluates link between lowering LDL-C and CV risk reduction across statin and nonstatin therapies

In a study appearing in the September 27 issue of JAMA, Marc S. Sabatine, M.D., M.P.H., of Brigham and Women's Hospital, Harvard Medical School, Boston, and colleagues evaluated the association between lowering low-density lipoprotein cholesterol (LDL-C) and relative cardiovascular risk reduction across different statin and nonstatin therapies.

27 Sep 2016

Acute Coronary Syndrome News and Research

SENIOR trial: Shorter DAPT combined with Synergy stent superior to BMS in elderly patients

Two protocols help assess patients with chest pain quickly and safely in emergency departments

New ESC Focused Update provides recommendations on DAPT in patients with coronary artery disease

University of Birmingham joins €19 million project to develop better treatments for heart disease

Study looks at role of race, gender in predicting heart attack symptoms in emergency department

Intensive blood pressure lowering reduces CKD patients' risks of heart disease and death

Philips showcase image guided therapy solutions at EuroPCR 2017

New stenting tool found to be less painful and cheaper than current methods

New iFR technique for assessing clogged arteries reduces discomfort and adverse events

Novel synthetic HDL-C injection shows no benefit on arterial plaques

High levels of two biomarkers can predict risk for adverse cardiac events, research suggests

Study finds only 16% of heart attack survivors get recommended amount of physical activity

European hospital introduces Philips Minicare cTnI point-of-care blood test for rapid diagnosis of heart attack

OU study identifies numeracy as decision delay risk factor for individuals experiencing ACS

Thought leaders at U-CARS meeting to explore issues related to heart recovery and regeneration

Study evaluates link between lowering LDL-C and CV risk reduction across statin and nonstatin therapies

New study reports both young men and women with ACS have good one-year prognosis

Benefits of cardioprotective drugs may extend beyond preventing acute coronary syndromes

New Focused Update to CCS atrial fibrillation guidelines released

OPTICARE study shows year-long CR program makes heart patients happier, healthier and active

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News